Cambridge, 02139, MA,
United States
Intellia Therapeutics Technographics
Intellia Therapeutics Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Intellia Therapeutics and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 598 Intellia Therapeutics employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Intellia Therapeutics has purchased the following applications: Oracle Cloud ERP for ERP Financial in 2020, Cisco Webex Meetings for Audio Video and Web Conferencing in 2017, DocuSign eSignature for Digital Signing in 2021 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Intellia Therapeutics is running and its propensity to invest more and deepen its relationship with Oracle , Cisco Systems , DocuSign or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Intellia Therapeutics revenues, which have grown to $52.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Intellia Therapeutics intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Intellia Therapeutics Tech Stack and Enterprise Applications
Intellia Therapeutics ERP
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Oracle | Legacy | Oracle Cloud ERP | ERP Financial | ERP | n/a | 2020 | 2021 |
In 2020, Intellia Therapeutics implemented Oracle Cloud ERP as its ERP Financial platform to consolidate clinical budgeting, forecasting, and reporting workflows. The Oracle Cloud ERP deployment targeted financial planning and analysis for clinical and regulatory study portfolios and the accounting controls that support those activities.
Configuration emphasized FP&A capabilities, project accounting, contract accruals, procurement requisition and change order controls, and accounts payable invoice reconciliation workflows. The system was used to support monthly Clinical Inception-to-Completion Cost Forecasts, quarterly updates to project consulting budgets, and regular budget to actual tracking for clinical and regulatory spend.
Operational integration aligned Finance with Clinical operations and trial leads to translate study protocols into budgets and head count forecasts, and it incorporated inputs from clinical and regulatory vendors to collect work status and accrual data. The deployment supported cross-functional workflows across Finance, Clinical, Regulatory, and Accounting teams for management reporting and quarterly contract accrual reviews.
Governance work focused on defining and improving processes for clinical study financial planning, accrual reporting, requisition approval, and ad hoc invoice reconciliation, with role expectations noting Oracle Fusion familiarity and strong Excel and presentation skills for analysis and stakeholder engagement. Change management established monthly and quarterly cadence rules for forecasts and accruals to standardize planning and transparent control over trial-related spend.
|
Intellia Therapeutics Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Cisco Systems | Legacy | Cisco Webex Meetings | Audio Video and Web Conferencing | Collaboration | n/a | 2017 | 2017 |
In 2017, Intellia Therapeutics implemented Cisco Webex Meetings, deploying the Audio Video and Web Conferencing capability on its public website. Cisco Webex Meetings provides web-embedded meeting join flows to support external-facing conferencing and internal team collaboration.
Configuration emphasized core meeting capabilities, including scheduled video conferences, screen sharing, in-meeting host and participant controls, and session recording for capture. The implementation of Cisco Webex Meetings included browser-native join experiences alongside client access, and standard conferencing controls were aligned with enterprise meeting workflows and moderation requirements.
The deployment was instrumented through the corporate website as the primary access point, enabling external stakeholders to initiate or join sessions directly from web pages. Governance was implemented at the platform level with administrative controls over meeting provisioning, access permissions, and recording retention policies to support corporate collaboration and external engagement in a life sciences context.
|
Intellia Therapeutics Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| DocuSign | Legacy | DocuSign eSignature | Digital Signing | Content Management | n/a | 2021 | 2021 |
In 2021, Intellia Therapeutics implemented DocuSign eSignature as a Digital Signing solution on its website. The deployment embeds DocuSign eSignature into the company website to capture legally enforceable signatures and to present executed documents to external parties, positioning Intellia Therapeutics DocuSign eSignature Digital Signing for online agreement and document execution workflows.
Configuration emphasizes web based signing ceremonies, document delivery, authentication controls, and audit trail capture consistent with the Digital Signing category. Integration is limited to the website as the signing endpoint, with site generated documents routed into DocuSign eSignature for signature capture and return of executed records, and governance centered on signature audit logs and retention controls provided by DocuSign eSignature.
|
Intellia Therapeutics CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Customer Experience | CRM |
|
2020 | 2020 |
|
|
|
|
|
Marketing Automation | CRM |
|
2019 | 2019 |
|
|
|
|
|
Marketing Automation | CRM |
|
2020 | 2020 |
|
Intellia Therapeutics Investment Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Portfolio and Investment Management | Investment Management |
|
2023 | 2023 |
|
Intellia Therapeutics PaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Transactional Email | PaaS |
|
2015 | 2015 |
|
Intellia Therapeutics IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2015 | 2015 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2022 | 2022 |
|
Intellia Therapeutics CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Identity and Access Management (IAM) | CyberSecurity |
|
2021 | 2021 |
|
|
|
|
|
Secure Email Gateways (SEGs) | CyberSecurity |
|
2017 | 2017 |
|
IT Decision Makers and Key Stakeholders at Intellia Therapeutics
Apps Being Evaluated by Intellia Therapeutics Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||